COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1815: Articles 18141-18150  | Next

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
Hassan, A. O., Feldmann, F., Zhao, H., Curiel, D. T., Okumura, A., Tang-Huau, T.-L., Case, J. B., Meade-White, K., Callison, J., Lovaglio, J., Hanley, P. W., Scott, D. P., Fremont, D. H., Feldmann, H., Diamond, M. S.
10.1101/2021.01.26.428251 — Posted: 2021-01-26
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Wang, P., Lihong, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P. D., Graham, B. S., Mascola, J. R., Chang, J. Y., Yin, M. T., Sobieszczyk, M. E., Kyratsous, C. A., Shapiro, L., Sheng, Z., Nair, M. S., Huang, Y., Ho, D. D.
10.1101/2021.01.25.428137 — Posted: 2021-01-26
Variant and mutation analysis of SARS-CoV-2 genomes isolated from the Kingdom of Bahrain
bindayna, K. M., Deifalla, A. H., Mokbel, H. E. M.
10.1101/2021.01.25.428191 — Posted: 2021-01-26
A novel SARS-CoV-2 related coronavirus in bats from Cambodia
Hul, V., Delaune, D., Karlsson, E. A., Hassanin, A., Ou Tey, P., Baidaliuk, A., Gambaro, F., Tu, V. T., Keatts, L., Mazet, J., Johnson, C., Buchy, P., Dussart, P., Goldstein, T., Simon-Loriere, E., Duong, V.
10.1101/2021.01.26.428212 — Posted: 2021-01-26 Discussion: Offsite
Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models
Dey, A., Rajanathan TM, C., Chandra, H., Pericherla, H. P., Kumar, S., Choonia, H. S., Bajpai, M., Singh, A. K., Sinha, A., Saini, G., Dalal, P., Vandriwala, S., Raheem, M. A., Divate, R. D., Navlani, N. L., Sharma, V., Parikh, A., Prasath, S., Rao, S., Maithal, K.
10.1101/2021.01.26.428240 — Posted: 2021-01-26
Colder and drier winter conditions are associated with greater SARS-CoV-2 transmission: a regional study of the first epidemic wave in north-west hemisphere countries.
Landier, J., Paireau, J., Rebaudet, S., Legendre, E., Le Hot, L., Fontanet, A., CAUCHEMEZ, S., Gaudart, J.
10.1101/2021.01.26.21250475 — Posted: 2021-01-26
Home-based management of COVID-19 by identification of low-risk features
Cabanillas, F., Morales, J., Bertran-Pasarell, J., Fernandez, R., Conde, J. G., Hernandez-Silva, Y., Liboy, I.
10.1101/2021.01.25.21249684 — Posted: 2021-01-26
Elevated HScore is Associated with Poor Clinical Outcomes in COVID-19, Even in the Absence of Secondary Hemophagocytic Lymphohistiocytosis.
Benavente, R., Pena, C., Cid, A., Cabello, N., Bustamante, P., Alvarez, M., Henriquez, E., Soto, A., Rubilar, E.
10.1101/2021.01.26.21249335 — Posted: 2021-01-26
Impact of social restrictions during the COVID-19 pandemic on the physical activity levels of older adults: an analysis of the CHARIOT COVID-19 Rapid Response Study
Salman, D., Beaney, T., Robb, C., Loots, C. A. d. J., Giannakopoulou, P., Udeh-Momoh, C., Ahmadi-Abhari, S., Majeed, A., Middleton, L. T., McGregor, A. H.
10.1101/2021.01.26.21250520 — Posted: 2021-01-26
Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries
Gaythorpe, K., Abbas, K., Huber, J., Karachaliou, A., Thakkar, N., Woodruff, K., Li, X., Echeverria-Londono, S., VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease, , Ferrari, M., Jackson, M. L., McCarthy, K., Perkins, A., Trotter, C., Jit, M.
10.1101/2021.01.25.21250489 — Posted: 2021-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).